Physician profile
Kelly Range
NPI 1063045821
$2,279.95
in general payments reported to CMS, 2019-2025
25 companies · $585 in 2025
The $585 reported for 2025 was more than what 79% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $269 · 2022: $373 · 2023: $211 · 2024: $842 · 2025: $585.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,638.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,637.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $697.39 | 2021-2025 | Signia, Ligasure, Endoflip |
| Novo Nordisk INC | $464.93 | 2021-2025 | Wegovy |
| Smith+Nephew, INC. | $219.08 | 2022-2025 | Grafix Pl, Stravix, Collagenase Santyl |
| W. L. Gore & Associates, INC. | $102.01 | 2021-2024 | Gore Synecor Biomaterial |
| Distalmotion US | $99.11 | 2025 | Dexter L6 Robot |
| Lilly USA, LLC | $80.33 | 2024-2025 | Zepbound |
| Intuitive Surgical, INC. | $70.41 | 2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $50.78 | 2022 | |
| Merck Sharp & Dohme LLC | $47.50 | 2023 | Bridion |
| Currax Pharmaceuticals LLC | $46.69 | 2021-2024 | Contrave |
| Eagle Pharmaceuticals, INC. | $45.63 | 2023 | |
| Integra Lifesciences Corporation | $41.03 | 2021-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Endo Pharmaceuticals INC. | $41.00 | 2021-2022 | |
| Innocoll Pharmaceuticals Limited | $37.97 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $30.59 | 2021-2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $29.20 | 2024-2025 | Enseal X1, Vistaseal |
| Baxter Healthcare | $26.95 | 2024 | Tisseel |
| Pacira Pharmaceuticals Incorporated | $25.00 | 2021 | |
| Solventum Corporation | $20.30 | 2025 | Prevena, V.A.C.Instill |
| Intra-Sana Laboratories | $19.73 | 2021 | |
| Angiodynamics, INC. | $19.22 | 2025 | Nanoknife |
| Teleflex LLC | $17.80 | 2023 | Titan Sgs Standard Gastric Stapler |
| Convatec INC. | $17.79 | 2024 | |
| Vertex Pharmaceuticals Incorporated | $16.63 | 2025 | |
| Bard Peripheral Vascular, INC. | $12.88 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kelly Range listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.